Abnormal high frequency oscillations (HFOs) in EEG recordings are thought to be reflections of mechanisms responsible for focal seizure generation in the temporal lobe and neocortex. HFOs have also been recorded in patients and animal models of infantile spasms. If HFOs are important contributors to infantile spasms then anticonvulsant drugs that suppress these seizures should decrease the occurrence of HFOs. In experiments reported here, we used long-term video/EEG recordings with digital sampling rates capable of capturing HFOs. We tested the effectiveness of vigabatrin (VGB) in the TTX animal model of infantile spasms. VGB was found to be quite effective in suppressing spasms. In 3 of 5 animals, spasms ceased after a daily two week treatment. In the other 2 rats, spasm frequency dramatically decreased but gradually increased following treatment cessation. In all animals, hypsarrhythmia was abolished by the last treatment day. As VGB suppressed the frequency of spasms, there was a decrease in the intensity of the behavioral spasms and the duration of the ictal EEG event. Analysis showed that there was a burst of high frequency activity at ictal onset, followed by a later burst of HFOs. VGB was found to selectively suppress the late HFOs of ictal complexes. VGB also suppressed abnormal HFOs recorded during the interictal periods. Thus VGB was found to be effective in suppressing both the generation of spasms and hypsarrhythmia in the TTX model. Vigabatrin also appears to preferentially suppress the generation of abnormal HFOs, thus implicating neocortical HFOs in the infantile spasms disease state.
Introduction
Over the past 15 years, there has been a growing appreciation of the importance of the high frequency content of EEGs in epilepsy research (Bragin et al., 2010; Jacobs et al., 2012; Zijlmans et al., 2012) . Brief bursts of high frequency oscillations (HFOs) in the range of 200-600 Hz have been recorded during interictal periods in both humans and animals models (Bragin et al., 2002a,b; Jirsch et al., 2006; Urrestarazu et al., 2007; Worrell et al., 2008; Schevon et al., 2009; Crepon et al., 2010; Jiruska et al., 2010) . While HFOs in the frequency range of 80-200 Hz are recorded in normal brains, abnormal HFOs at these and higher frequencies have been shown to be closely associated with suspected sites of seizure generation. They have also been reported to occur at the onset of seizures (Bragin et al., 2005; Jacobs et al., 2008) . Thus abnormal HFOs have been suggested to be a biomarker of sites of seizure generation and are currently beginning to be used to guide epilepsy surgery (Zijlmans et al., 2012) .
If abnormal HFOs are important contributors to epilepsy, then one would predict that the occurrence of these events should decrease upon treatment with anticonvulsant drugs. To our knowledge such studies have not been performed in humans or animal models. However, one study has reported that HFOs become more frequent in patients after a reduction in antiepileptic drug treatment (Zijlmans et al., 2009) .
Neurophysiological studies of epileptic spasms in humans and an animal model have reported the presence of abnormal HFOs in EEG recordings (Panzica et al., 2007; Frost et al., 2011 Frost et al., , 2012 Nariai et al., 2011a,b) . Infantile spasms is the most common form of epileptic spasms. The neurobiological basis for these brief seizures is unknown but results from clinical studies have implicated a possible interaction between abnormal neocortical and subcortical circuits in their generation (Chugani et al., 1992; Dulac et al., 2002; Lado and Moshe, 2002; Hrachovy and Frost, 2003) . A neocortical contribution of abnormal HFOs to spasm generation is supported by recent recordings in both humans and animals (Frost et al., 2011 (Frost et al., , 2012 Nariai et al., 2011a,b) . 
